WallStreetZenWallStreetZen

NASDAQ: BMRN
Biomarin Pharmaceutical Inc Stock Ownership - Who owns Biomarin Pharmaceutical?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Biomarin Pharmaceutical Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alexander HardyChief Executive Officer2025-12-0116,570$55.03
$911.85kSell
Cristin HubbardEVP Chief Commercial Officer2025-10-3180$45.54
$3.64kBuy
Gregory R. FribergEVP Chief RD Officer2025-10-31398$45.54
$18.12kBuy
Charles Greg GuyerEVP Chief Technical Officer2025-10-3162$45.54
$2.82kBuy
Gregory R. FribergEVP Chief RD Officer2025-09-303,304$54.16
$178.94kSell
Cristin HubbardEVP Chief Commercial Officer2025-05-202,155$59.93
$129.15kSell
Erin BurkhartGVP Chief Accounting Officer2025-05-201,786$59.31
$105.93kSell
Erin BurkhartGVP Chief Accounting Officer2025-05-19996$59.27
$59.03kSell
Cristin HubbardEVP Chief Commercial Officer2025-05-02273$64.92
$17.72kSell
Brian MuellerEVP Chief Financial Officer2025-04-30375$54.14
$20.30kBuy

1 of 3

BMRN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BMRN insiders and whales buy or sell their stock.

BMRN Shareholders

What type of owners hold Biomarin Pharmaceutical Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc9.96%19,135,108$1.15BInstitution
Vanguard Group Inc9.44%18,127,847$1.09BInstitution
Dodge Cox7.59%14,572,384$872.45MInstitution
Primecap Management Co7.57%14,549,314$871.07MInstitution
Norges Bank3.92%7,531,080$450.89MInstitution
State Street Corp3.92%7,523,218$450.42MInstitution
Geode Capital Management LLC1.91%3,674,089$219.97MInstitution
Dimensional Fund Advisors LP1.73%3,321,754$198.87MInstitution
Capital Research Global Investors1.33%2,547,287$152.51MInstitution
Morgan Stanley1.21%2,315,620$138.64MInstitution

1 of 3

BMRN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BMRN73.06%1.74%Net SellingNet Selling
EXEL73.35%5.67%Net SellingNet Selling
SMMT3.67%96.33%Net Buying
MDGL12.20%87.80%Net BuyingNet Selling
RNA46.06%11.50%Net SellingNet Selling
View Top Biotech Stocks

Biomarin Pharmaceutical Stock Ownership FAQ

Who owns Biomarin Pharmaceutical?

Biomarin Pharmaceutical (NASDAQ: BMRN) is owned by 73.06% institutional shareholders, 1.74% Biomarin Pharmaceutical insiders, and 25.20% retail investors. Jean Jacques Bienaime is the largest individual Biomarin Pharmaceutical shareholder, owning 962,817.00 shares representing 0.50% of the company. Jean Jacques Bienaime's Biomarin Pharmaceutical shares are currently valued at $57.72M.

If you're new to stock investing, here's how to buy Biomarin Pharmaceutical stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.